The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: capecitabine     Quarter: 2016Q3

Total Drug/Injury Combinations: 914     Number of Pages: 46

DRUGNAME PT EventCount
CAPECITABINE. Urinary tract disorder 1 view events
CAPECITABINE. Urinary tract pain 1 view events
CAPECITABINE. Uterine haemorrhage 1 view events
CAPECITABINE. Vaginal disorder 1 view events
CAPECITABINE. Vaginal perforation 1 view events
CAPECITABINE. Vascular access complication 1 view events
CAPECITABINE. Vascular rupture 1 view events
CAPECITABINE. Vein disorder 1 view events
CAPECITABINE. Vertebral column mass 1 view events
CAPECITABINE. Viral infection 1 view events
CAPECITABINE. White blood cell count abnormal 1 view events
CAPECITABINE. White blood cell count increased 1 view events
CAPECITABINE. Wrong technique in product usage process 1 view events
CAPECITABINE. Xeroderma 1 view events

Total Drug/Injury Combinations: 914     Number of Pages: 46

NOTE: EventCount numbers on this page include duplicate entries from event reports. (e.g. One event has DrugX entered twice, which equals 2 on this page.) The "view events" page treats these duplicates as single entries. (e.g. The 2 entries of DrugX for a single event are counted as 1 instance.)